Yuping Mei
Papers
1
Total Citations
9
H-Index
1
About
Yuping Mei is a translational researcher whose work focuses on the early, non-invasive detection of lung cancer—a critical frontier in oncology. Her primary research areas include liquid biopsy biomarkers, small non-coding RNAs, and the molecular characterization of pulmonary nodules. Mei’s most notable contribution is the development of a cost-effective, non-invasive test based on plasma protein functional effector sncRNAs (pfeRNAs). As detailed in her highly cited 2021 paper, this pfeRNA-based assay can accurately differentiate between benign, suspicious, and malignant pulmonary nodules, addressing a major clinical dilemma: how to avoid unnecessary invasive procedures for benign lesions while ensuring timely intervention for early-stage lung cancers. This work has garnered significant attention (9 citations) for its potential to transform lung cancer screening protocols. By leveraging circulating sncRNAs, Mei has pioneered a strategy that is both accessible and precise, offering a practical alternative to traditional biopsy. Her achievements underscore a commitment to bridging molecular biology with clinical utility, making her a key figure in the push toward personalized, non-invasive cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1